# Spinal Cord Neuromodulation for Spinal Cord Injury

> **NCT02313194** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 12 (estimated)

## Conditions studied

- Cervical Spinal Cord Injury
- Tetraparesis
- Tetraplegia

## Interventions

- **DEVICE:** Epidural Stimulation
- **DRUG:** Buspirone

## Key facts

- **NCT ID:** NCT02313194
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-07
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313194, "Spinal Cord Neuromodulation for Spinal Cord Injury". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02313194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*